Filtros de búsqueda

Lista de obras de

Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model.

artículo científico publicado en 2014

Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma

DOTA-functionalized polylysine: a high number of DOTA chelates positively influences the biodistribution of enzymatic conjugated anti-tumor antibody chCE7agl

artículo científico publicado en 2013

Evaluation of 177Lu-DOTA-labeled aglycosylated monoclonal anti-L1-CAM antibody chCE7: influence of the number of chelators on the in vitro and in vivo properties

artículo científico publicado en 2006

Future prospects for SPECT imaging using the radiolanthanide terbium-155 - production and preclinical evaluation in tumor-bearing mice

artículo científico publicado en 2013

Hepatocyte growth factor-induced ectodomain shedding of cell adhesion molecule L1: role of the L1 cytoplasmic domain

artículo científico publicado en 2004

High-yield production of recombinant antibody fragments in HEK-293 cells using sodium butyrate

artículo científico publicado en 2003

Imaging of renal carcinoma xenografts with 64Cu-labelled anti-L1-CAM antibody chCE7.

artículo científico publicado en 2003

In vivo evaluation of 177Lu- and 67/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors.

artículo científico publicado en 2005

L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population

scientific article published on 15 January 2020

L1-CAM-targeted antibody therapy and 177Lu-radioimmunotherapy of disseminated ovarian cancer

artículo científico publicado en 2011

Modification of different IgG1 antibodies via glutamine and lysine using bacterial and human tissue transglutaminase

artículo científico publicado en 2007

Novel Therapeutic Strategies for Ovarian Cancer Stem Cells

scientific article published on 17 March 2020

Paclitaxel improved anti-L1CAM lutetium-177 radioimmunotherapy in an ovarian cancer xenograft model

artículo científico publicado en 2014

Radiometal labeling of antibodies and antibody fragments for imaging and therapy.

artículo científico publicado en 2004

Site-specific and stoichiometric modification of antibodies by bacterial transglutaminase

artículo científico publicado en 2010

Targeting Cancer Stem Cells with Radioimmunotherapy: The Case of the Ovarian Cancer Stemness-Associated Biomarker L1CAM

artículo científico publicado en 2024

Targeting of renal carcinoma with 67/64Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imaging.

artículo científico publicado en 2003

The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy

artículo científico publicado en 2011

The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor.

artículo científico publicado en 2009